• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ALUNG TECHNOLOGIES, INC. HEMOLUNG RAS; EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19 Back to Search Results
Model Number HL-CR4-01-000
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Septic Shock (2068)
Event Date 09/14/2020
Event Type  Injury  
Event Description
Alung technologies, inc.Received a report of a patient in septic shock during eua hemolung therapy.Hemolung therapy was discontinued as a result of this event.
 
Manufacturer Narrative
Alung technologies, inc.Manufactures the hemolung ras and catheter.The incident occurred in minneapolis, minnesota.Withdarwal of therapy was the outcome of the event.Through review of the expanded access form, it was noted that the patient experienced sepsis or septic shock.This led to discontinuation of therapy.The data log from therapy has been retrieved and reviewed by both clinical and software engineering staff.No abnormalities were noted within the co2 removal and blood flow graphs.Therapy was provided as intended.No capa was opened because of this event.Sepsis/septic shock is a known complication associated with use of extracorporeal therapy.There is no indication of cause of sepsis reported.Examination of the controller data log shows that therapy was provided as intended.Alung technologies, inc.Will continue to monitor any issues as they are reported.This mdr is being filed in response to a retrospective view of all alung technologies, inc.Complaints, which identified that the reporting decision for this complaint was not correct.This mdr is being filed retrospectively to correct the error in the reporting decision.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEMOLUNG RAS
Type of Device
EXTRACORPOREAL SYSTEM FOR CARBON DIOXIDE REMOVAL FOR THE TREATMENT OF COVID-19
Manufacturer (Section D)
ALUNG TECHNOLOGIES, INC.
2500 jane st
suite 1
pittsburgh PA 15203
Manufacturer Contact
ryan coyle
2500 jane st
suite 1
pittsburgh, PA 15203
MDR Report Key16211834
MDR Text Key307765924
Report Number3009763347-2023-00078
Device Sequence Number1
Product Code QLN
UDI-Device Identifier00850046004346
UDI-Public(01)00850046004346(17)200101
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
DEN210006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 01/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberHL-CR4-01-000
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received10/07/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/01/2020
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Life Threatening;
Patient Age59 YR
Patient SexMale
-
-